JOURNAL OF HEADACHE AND PAIN

Scope & Guideline

Fostering Collaboration in Headache and Pain Research

Introduction

Welcome to your portal for understanding JOURNAL OF HEADACHE AND PAIN, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1129-2369
PublisherBMC
Support Open AccessYes
CountryItaly
TypeJournal
Convergefrom 2001 to 2024
AbbreviationJ HEADACHE PAIN / J. Headache Pain
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The Journal of Headache and Pain focuses on disseminating research findings that advance the understanding, diagnosis, and treatment of headache disorders. The journal aims to cover a wide range of topics related to headache, including epidemiology, pathophysiology, clinical management, and novel therapeutic strategies.
  1. Epidemiology and Burden of Headache Disorders:
    Research that evaluates the prevalence, incidence, and socioeconomic impact of various headache types, including migraine, tension-type headaches, and cluster headaches.
  2. Pathophysiology and Mechanisms of Headache:
    Studies exploring the biological, neurological, and genetic underpinnings of headache disorders, including neuroinflammation, neurotransmitter pathways, and genetic susceptibility.
  3. Clinical Management and Treatment Strategies:
    Articles discussing pharmacological and non-pharmacological treatment approaches, including the use of monoclonal antibodies, neuromodulation techniques, and lifestyle interventions in headache management.
  4. Psychosocial and Quality of Life Aspects:
    Research investigating the psychological impact of headaches on patients, including comorbid conditions, mental health, and quality of life assessments.
  5. Innovative Diagnostic and Therapeutic Approaches:
    Papers focusing on advancements in diagnostic tools, imaging techniques, and emerging therapies for headache disorders.
  6. Global Perspectives on Headache Care:
    Research that addresses the disparities in headache care across different regions, including access to treatment and cultural factors influencing management.
The Journal of Headache and Pain is witnessing an increase in research focused on innovative approaches and contemporary issues in headache management. This section outlines the trending and emerging themes that are shaping the future of headache research.
  1. CGRP Pathway and Monoclonal Antibodies:
    There is a significant surge in research related to the calcitonin gene-related peptide (CGRP) pathway, with numerous studies assessing the efficacy and safety of CGRP monoclonal antibodies in migraine prevention and treatment.
  2. Telemedicine and Digital Health Solutions:
    The impact of telemedicine on headache management has gained traction, particularly following the COVID-19 pandemic, with research exploring the effectiveness of remote consultations and digital health interventions.
  3. Neuroinflammation and its Role in Headaches:
    Emerging studies are increasingly focusing on neuroinflammation as a critical factor in the pathophysiology of headaches, leading to a better understanding of chronic headache mechanisms.
  4. Psychological Aspects and Comorbidities:
    Research is trending towards understanding the interplay between psychological factors, such as anxiety and depression, and their impact on headache disorders, emphasizing the need for holistic management.
  5. Personalized and Precision Medicine Approaches:
    An increase in studies exploring personalized treatment strategies based on genetic, phenotypic, and psychosocial profiles of headache patients is becoming evident.

Declining or Waning

As the field of headache research evolves, certain themes appear to be less prevalent in recent publications compared to earlier years. This section highlights these waning scopes that may indicate shifts in research priorities or emerging trends.
  1. Traditional Pharmacological Treatments:
    There is a noticeable decrease in studies focused solely on traditional medications like triptans and analgesics, as newer therapies such as anti-CGRP monoclonal antibodies gain prominence in research.
  2. Non-Evidence-Based Treatments:
    Research on non-evidence-based or anecdotal treatments for headache disorders is less frequently published, reflecting a shift towards evidence-based medicine and clinical trials.
  3. Unidimensional Studies:
    There is a decline in studies that focus solely on one-dimensional aspects of headache without integrating psychosocial or multidimensional health outcomes.
  4. Overreliance on Retrospective Studies:
    A reduction in the number of retrospective studies as the field increasingly values prospective, randomized controlled trials and real-world evidence.

Similar Journals

Clinical Parkinsonism & Related Disorders

Unlocking the mysteries of Parkinson's and related conditions.
Publisher: ELSEVIERISSN: Frequency: 2 issues/year

Clinical Parkinsonism & Related Disorders is a prominent open-access journal published by Elsevier, focused on advancing the understanding and treatment of Parkinson's disease and related neurological conditions. Since its inception in 2019, this journal has aimed to provide a platform for high-quality research, review articles, and clinical studies dedicated to elucidating the complexities of Parkinsonism and its comorbidities. With an E-ISSN of 2590-1125, it has swiftly established its role in the field of clinical neurology, currently ranked in the Q3 quartile for clinical neurology and Q4 for cellular and molecular neuroscience. While its Scopus rankings reflect a competitive landscape, occupying the 241st position in clinical neurology and the 83rd in neuroscience, the journal remains committed to fostering scholarly dialogue and supporting innovative research. Researchers, clinicians, and students will find valuable insights within its pages, contributing to ongoing discourse and the pursuit of effective therapeutic strategies. Access to all articles has been made available since 2019, emphasizing the journal's mission to disseminate knowledge widely and enhance accessibility in the scientific community.

HEADACHE

Elevating Understanding of Neurological Pain
Publisher: WILEYISSN: 0017-8748Frequency: 10 issues/year

HEADACHE is a premier academic journal dedicated to advancing the study of headache disorders through innovative research and clinical insights. Published by WILEY, this influential journal has been serving the neurology community since its inception in 1961 and is recognized as a leader in its field, boasting an impressive Q1 ranking in both Neurology and Neurology (clinical) categories for 2023. With a robust Scopus ranking of #48 in clinical neurology and #26 in neuroscience, HEADACHE consistently publishes high-quality research that contributes to the understanding and treatment of headache disorders worldwide. Although it does not offer open access options, the journal remains accessible to a wide audience through various institutional subscriptions. It aims to provide a platform for researchers, healthcare professionals, and students to exchange ideas and develop new strategies for headache management, making it an essential resource for those dedicated to improving patient outcomes in this challenging area of healthcare.

Multiple Sclerosis and Related Disorders

Unraveling the complexities of multiple sclerosis and beyond.
Publisher: ELSEVIER SCI LTDISSN: 2211-0348Frequency: 6 issues/year

Multiple Sclerosis and Related Disorders, published by Elsevier Science Ltd, is a leading journal that serves as a vital resource in the field of neurology, particularly focused on multiple sclerosis and its associated conditions. This esteemed journal, which holds a Q1 ranking in Medicine (miscellaneous) and Q2 ranking in both Neurology and Clinical Neurology, delivers high-impact research findings and clinical insights crucial for advancing the understanding and management of multiple sclerosis. With an ISSN of 2211-0348 and an E-ISSN of 2211-0356, it provides valuable content from 2012 to 2024 aimed at researchers, healthcare professionals, and students dedicated to improving patient outcomes and fostering innovative strategies in treatment. Additionally, the journal's presence in the Scopus rankings highlights its relevance and influence in the academic community, ranking 121 out of 400 in Clinical Neurology and 59 out of 192 in Neuroscience. This comprehensive platform encourages the dissemination of cutting-edge knowledge and clinical practices, making it an essential tool for those committed to the field of neurology and related research.

NEUROMUSCULAR DISORDERS

Pioneering research for better patient outcomes.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-8966Frequency: 12 issues/year

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

EUROPEAN NEUROLOGY

Advancing the Frontiers of Neurological Science
Publisher: KARGERISSN: 0014-3022Frequency: 6 issues/year

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.

Neuropsychiatric Disease and Treatment

Exploring the Frontiers of Neuropsychiatric Science
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Neuropsychiatric Disease and Treatment, published by DOVE MEDICAL PRESS LTD, is a prominent open access journal dedicated to advancing the field of neuropsychiatry. Since its inception in 2009, this journal has provided a platform for the dissemination of high-quality research on innovative therapies and treatments for neuropsychiatric disorders. With an impressive Q2 ranking in Psychiatry and Mental Health and a Q3 ranking in Biological Psychiatry as of 2023, it holds a reputable position within the scholarly community, reflecting its commitment to impactful research. The journal's open access model ensures widespread accessibility, fostering collaboration and dialogue among researchers, clinicians, and students worldwide. The journal accepts a variety of article types, including original research, reviews, and case studies, encompassing a range of topics from pathophysiology to therapeutic advancements. With its base in New Zealand and a Scopus rank placing it within the 69th percentile of Psychiatry and Mental Health, Neuropsychiatric Disease and Treatment is an essential resource for those dedicated to understanding and treating the complexities of neuropsychiatric conditions.

Annals of Clinical and Translational Neurology

Unlocking the Future of Neurological Care
Publisher: WILEYISSN: 2328-9503Frequency: 12 issues/year

Annals of Clinical and Translational Neurology is a premier journal published by WILEY, focusing on the fields of neurology and neuroscience. Since its inception in 2014, it has established itself as an Open Access platform, providing unrestricted access to cutting-edge research to promote scientific collaboration and innovation. With an impressive Impact Factor residing in the top quartile (Q1) for both clinical neurology and miscellaneous neuroscience in 2023, this journal ranks #52 out of 400 in the Neurology category and #22 out of 113 in General Neuroscience, indicating its significant contribution to the field. The journal welcomes submissions that address emerging trends and challenges in translational neurology, aiming to bridge the gap between laboratory research and clinical practice. By disseminating high-quality research and fostering a community of scholars, Annals of Clinical and Translational Neurology plays a vital role in advancing our understanding of neurological disorders and improving patient care worldwide.

Pain Research & Management

Elevating Standards in Pain Medicine Through Open Access
Publisher: HINDAWI LTDISSN: 1203-6765Frequency:

Pain Research & Management, published by HINDAWI LTD, is a leading academic journal that serves as a vital resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and neurology. With an impressive impact factor and categorized in the second quartile (Q2) for both anesthesiology and neurology as of 2023, the journal features high-quality, peer-reviewed research articles that address the complexities of pain management. Established in 1996 and recognized as Open Access, this journal allows unrestricted access to groundbreaking studies, thereby facilitating knowledge dissemination and collaboration within the global scientific community. With a strong ranking—34/136 in anesthesiology and 72/192 in neurology—Pain Research & Management retains a well-deserved reputation for publishing innovative and authoritative content that significantly contributes to the advancement of pain research and clinical practice. Researchers and healthcare professionals alike will find this journal indispensable for staying abreast of the latest discoveries and best practices in pain management.

Journal of Hematology

Connecting Scholars, Enhancing Practice
Publisher: ELMER PRESS INCISSN: 1927-1212Frequency: 4 issues/year

The Journal of Hematology, published by ELMER PRESS INC, serves as a pivotal platform for disseminating cutting-edge research in the field of hematology. With an ISSN of 1927-1212 and an E-ISSN of 1927-1220, this journal is committed to advancing scientific knowledge and clinical practice through high-quality peer-reviewed articles encompassing all aspects of blood disorders, from basic science to health policy implications. While the journal currently operates under a traditional access model, it nonetheless prioritizes the rapid publication of significant findings, ensuring that researchers, clinicians, and students have timely access to the latest advancements in hematological research. Positioned to bridge gaps in knowledge and foster collaboration among scholars worldwide, the Journal of Hematology is an essential resource for anyone invested in this vital area of medicine.

Epilepsy & Behavior Reports

Exploring Innovations in Epilepsy Research and Treatment
Publisher: ELSEVIER SCIENCE INCISSN: Frequency: 1 issue/year

Epilepsy & Behavior Reports, a distinguished journal published by ELSEVIER SCIENCE INC, specializes in the latest research and developments in the field of epilepsy and related behavioral conditions. Since its inception in 2019 as a fully Open Access journal, it has carved a niche for itself within the scientific community, providing an essential platform for researchers and clinicians focused on behavioral neuroscience and neurology. The journal's commitment to disseminating high-quality research is reflected in its current rankings within Scopus, placing it within the Q3 category for Behavioral Neuroscience and Clinical Neurology, underscoring its relevance to emerging trends in these fields. Located in the heart of New York, the journal strives to foster collaboration and innovation, making it a vital resource for academics, practitioners, and students eager to advance their understanding of epilepsy and its behavioral implications. The convergence of expertise and research in Epilepsy & Behavior Reports promises to illuminate crucial aspects of neurological health, driving forward the discourse that shapes future treatment and understanding of epilepsy.